FORM OF SUBSCRIPTION AGREEMENTSubscription Agreement • March 26th, 2012 • Astex Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 26th, 2012 Company Industry Jurisdictiono A. Delivery by crediting the account of the Investor’s prime broker (as specified by such Investor on Exhibit A annexed hereto) through the Depository Trust Company’s (“DTC”) Deposit/Withdrawal At Custodian (“DWAC”) system, whereby Investor’s prime broker shall initiate a DWAC transaction on the Closing Date using its DTC participant identification number, and the Shares are released by [insert name of transfer agent], the Company’s transfer agent (the “Transfer Agent”), at the Company’s direction. NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE INVESTOR AND THE COMPANY, THE INVESTOR SHALL:
SUBSCRIPTION AGREEMENTSubscription Agreement • December 7th, 2006 • Acusphere Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 7th, 2006 Company Industry Jurisdiction[____] A. Delivery by electronic book-entry at The Depository Trust Company (“DTC”), registered in the Investor’s name and address as set forth below, and released by American Stock Transfer & Trust Company, the Company’s transfer agent (the “Transfer Agent”), to the Investor at the Closing (as defined in Section 3.1 of Annex I hereto). NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE INVESTOR AND THE COMPANY, THE INVESTOR SHALL:
SUBSCRIPTION AGREEMENTSubscription Agreement • April 7th, 2006 • Acusphere Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 7th, 2006 Company Industry Jurisdictiono A. Delivery by electronic book-entry at The Depository Trust Company (“DTC”), registered in the Investor’s name and address as set forth below, and released by American Stock Transfer & Trust Company, the Company’s transfer agent (the “Transfer Agent”), to the Investor at the Closing. NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE INVESTOR AND THE COMPANY, THE INVESTOR SHALL: